Development of nucleic acid medicines

Bonac utilizes its unique technology on nucleic acid to develop treatment drugs as well as technology that can be applied to treatment of intractable disorders with high medical needs.

We have focused on intractable disorders such as idiopathic pulmonary fibrosis and COVID-19 and are aiming to conduct research and development to improve therapeutic effects through direct administration of nucleic acid to the affected area. By utilizing the characteristics of nucleic acid, we work towards creating novel pharmaceutical products and improving the previously developed pharmaceutical products.